CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,284,548 | +85.5% | 1,589,931 | +12.4% | 3.14% | +106.2% |
| Q2 2023 | $25,495,110 | +12.2% | 1,414,823 | 0.0% | 1.52% | -7.4% |
| Q1 2023 | $22,722,057 | -12.2% | 1,414,823 | 0.0% | 1.64% | +2.2% |
| Q4 2022 | $25,891,261 | -6.8% | 1,414,823 | 0.0% | 1.61% | -24.8% |
| Q3 2022 | $27,787,000 | +5.3% | 1,414,823 | 0.0% | 2.14% | -14.1% |
| Q2 2022 | $26,386,000 | -15.0% | 1,414,823 | 0.0% | 2.49% | -5.9% |
| Q1 2022 | $31,055,000 | – | 1,414,823 | – | 2.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |